These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
121 related articles for article (PubMed ID: 3866114)
1. Unexpected absence of a myeloid surface antigen (3-fucosyl-N-acetyllactosamine) in promyelocytic leukemia. Bettelheim P; Panzer S; Majdic O; Stockinger H; Roithner A; Köller U; Meryn S; Lechner K; Knapp W Leuk Res; 1985; 9(11):1323-7. PubMed ID: 3866114 [TBL] [Abstract][Full Text] [Related]
2. Early expression of MCS2 (CD13) in the cytoplasm of blast cells from acute myeloid leukaemia. Pombo de Oliveira MS; Matutes E; Rani S; Morilla R; Catovsky D Acta Haematol; 1988; 80(2):61-4. PubMed ID: 2901804 [TBL] [Abstract][Full Text] [Related]
3. Detection of the granulocyte-specific antigen 3-fucosyl-N-acetyl-lactosamine on leukemic cells after neuraminidase treatment. Tetteroo PA; van't Veer MB; Tromp JF; von dem Borne AE Int J Cancer; 1984 Mar; 33(3):355-8. PubMed ID: 6199317 [TBL] [Abstract][Full Text] [Related]
4. Immunophenotyping of acute myeloid leukemia using monoclonal antibodies and the alkaline phosphatase-antialkaline phosphatase technique. Hanson CA; Gajl-Peczalska KJ; Parkin JL; Brunning RD Blood; 1987 Jul; 70(1):83-9. PubMed ID: 3297208 [TBL] [Abstract][Full Text] [Related]
5. In vitro induction of myeloid surface markers in a rare case of acute leukemia. Drexler HG; Coustan-Smith E; Gignac SM; Jani H; Hoffbrand AV Am J Hematol; 1987 Aug; 25(4):441-8. PubMed ID: 3303919 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the individual and combined reactivities of monoclonal antibodies H25, H366, and MY9 with normal progenitor cells and blast cells from patients with acute myeloblastic leukemia. Wisniewski D; Strife A; Arlin Z; Knowles R; Lambek C; Gulati S; McHendry B; McKenzie S; Clarkson B Leukemia; 1989 Jun; 3(6):446-52. PubMed ID: 2657231 [TBL] [Abstract][Full Text] [Related]
7. Expression of SSEA-I antigen (3-fucosyl-N-acetyl-lactosamine) on normal and leukaemic human haemopoietic cells: modulation by neuraminidase treatment. Tabilio A; Del Canizo MC; Henri A; Guichard J; Mannoni P; Civin CI; Testa U; Rochant H; Vainchenker W; Breton-Gorius J Br J Haematol; 1984 Dec; 58(4):697-710. PubMed ID: 6083798 [TBL] [Abstract][Full Text] [Related]
8. Reactivity pattern of 'myeloid monoclonal antibodies' with emphasis on MCS-2. Drexler HG; Sagawa K; Menon M; Minowada J Leuk Res; 1986; 10(1):17-23. PubMed ID: 3456072 [TBL] [Abstract][Full Text] [Related]
10. Prognostic significance of surface marker expression on blasts of patients with de novo acute myeloblastic leukemia. Schwarzinger I; Valent P; Köller U; Marosi C; Schneider B; Haas O; Knapp W; Lechner K; Bettelheim P J Clin Oncol; 1990 Mar; 8(3):423-30. PubMed ID: 2307987 [TBL] [Abstract][Full Text] [Related]
11. Correlation of surface marker expression with morphologically and immunologically defined subclasses of acute myeloid leukaemias. Drexler HG; Menon M; Klein M; Bhoopalam N; Messmore HL; Minowada J Clin Exp Immunol; 1986 Aug; 65(2):363-72. PubMed ID: 3466728 [TBL] [Abstract][Full Text] [Related]
12. Reactivity patterns of monoclonal antibodies positive on myelomonocytic leukemia cells as defined by esterase isoenzyme analysis. Drexler HG; Menon M; Gaedicke G; Minowada J Cancer Immunol Immunother; 1986; 21(3):188-92. PubMed ID: 3457629 [TBL] [Abstract][Full Text] [Related]
13. Characterization of myeloid leukemias with monoclonal antibodies 3C5 and MY9. Matutes E; Rodriguez B; Polli N; Tavares de Castro J; Parreira A; Andrews C; Griffin JD; Tindle RW; Catovsky D Hematol Oncol; 1985; 3(3):179-86. PubMed ID: 3862640 [TBL] [Abstract][Full Text] [Related]
14. Antigenic phenotype of the myeloid leukaemic cells defined by monoclonal antibodies. Robak T; Korycka A Arch Immunol Ther Exp (Warsz); 1987; 35(1):33-42. PubMed ID: 3477133 [TBL] [Abstract][Full Text] [Related]
15. A monoclonal antibody reactive with normal and leukemic human myeloid progenitor cells. Griffin JD; Linch D; Sabbath K; Larcom P; Schlossman SF Leuk Res; 1984; 8(4):521-34. PubMed ID: 6590930 [TBL] [Abstract][Full Text] [Related]
16. Staging of leukemic progenitor cells in acute myeloid leukemia by phenotyping with myeloid monoclonal antibodies. Hast R; Dowding C; Robak T; Goldman JM Exp Hematol; 1986 Nov; 14(10):981-7. PubMed ID: 3464449 [TBL] [Abstract][Full Text] [Related]
17. M2, a novel myelomonocytic cell surface antigen and its distribution on leukemic cells. Majdic O; Bettelheim P; Stockinger H; Aberer W; Liszka K; Lutz D; Knapp W Int J Cancer; 1984 May; 33(5):617-23. PubMed ID: 6724736 [TBL] [Abstract][Full Text] [Related]
18. Expression of monocytic and T-lymphocytic phenotype in a variant form of acute promyelocytic leukaemia (M3). Sato T; Abe R; Kawaguchi M; Uchida T; Kariyone S Scand J Haematol; 1986 Aug; 37(2):151-3. PubMed ID: 3489982 [TBL] [Abstract][Full Text] [Related]
19. Application of series of monoclonal antibodies against human white cell differentiation antigens and the common ALL antigen in the characterization of leukemia cells. Hołowiecki J; Stella-Hołowiecka B; Krawczyk-Kuliś M; Wiechnik E; Japa J; Jarczok K; Rudzka E; Duraj M Arch Immunol Ther Exp (Warsz); 1984; 32(1):43-9. PubMed ID: 6433853 [TBL] [Abstract][Full Text] [Related]
20. A unique antigen expressed on myeloid cells and acute leukemia blast cells defined by a monoclonal antibody. Ball ED; Graziano RF; Fanger MW J Immunol; 1983 Jun; 130(6):2937-41. PubMed ID: 6574189 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]